The EST mice induced a rise in survivin immune reactivity tumor, and the treatment of EST with both APAN +ETO was more effective rather than treatment with one of them alone to reduce these survivin expressions (Figure 10, Table 3). The gene discussed is BIRC5; the disease is neoplasm.